OXNARD, Calif., April 15, 2015 (GLOBE NEWSWIRE) -- Clean Diesel Technologies, Inc. (Nasdaq: CDTI ) ("CDTi" or "the Company"), a leader in advanced emission control technology, announced its Chief Technology Officer, Dr. Stephen Golden, will present a paper titled: "Novel Mixed Metal Oxide Structure for Next Generation Three-Way Catalysts (TWCs)" on April 22 nd at 9:00 a.m. in Room 140F at the SAE 2015 World Congress at the Cobo Center in Detroit, Michigan.
Dr. Golden's presentation will outline the underpinnings of the Spinel™ technology patents granted to the Company in 2014 – the promising new technology for which on-vehicle testing is currently being conducted.
The presentation and white paper will be available via CDTi's website prior to the event.
For meeting inquiries at SAE 2015, interested parties may call LHA at +1 415 433 3777.
About CDTi
CDTi manufactures and distributes vehicle emissions control products that leverage its advanced materials technology. CDTi utilizes its proprietary patented Mixed Phase Catalyst (MPC®) technology and other related technologies to provide high-value sustainable solutions to reduce emissions, increase energy efficiency and lower the carbon intensity of on- and off-road combustion engine systems. Reflecting its continued focus on innovation, CDTi is developing and commercializing proprietary advanced low-platinum group metal (PGM) catalysts including synergized-PGM (SPGM™), as well as zero-PGM (ZPGM™) catalysts. CDTi is headquartered in Oxnard, California and has operations in the U.K., Canada, France, Japan and Sweden. For more information, please visit www.cdti.com .
Forward-Looking Statements
Certain information contained in this press release constitutes forward-looking statements, including any statements contained herein that are not statements of historical fact. You can identify these forward-looking statements by the use of the words "believes", "expects", "anticipates", "plans", "may", "will", "would", "intends", "estimates", and other similar expressions, whether in the negative or affirmative. Forward-looking statements are based on a series of expectations, assumptions, estimates and projections which involve substantial uncertainty and risk. In this press release, the Company includes forward looking statements regarding Dr. Golden's proposed presentation, promise of Spinel technology patents, and the development, commercialization and benefits of CDTi's technologies. In general, actual results may differ materially from those indicated by such forward-looking statements as a result of risks and uncertainties, including, but not limited, to (i) any inability by CDTi to (1) realize the benefits of investments; (2) successfully transition into an advanced materials supplier; (3) execute its strategic priorities; (4) commercialize its technology due to agreements with third parties; (5) protect its intellectual property; (6) obtain verifications, approvals or market acceptance of its products or technology; or (7) achieve anticipated results; (ii) changes in or lack of enforcement of or funding for emissions programs, regulations or standards; (iii) competitive conditions; (iv) prices of PGM and rare earth metals; (v) intellectual property infringement allegations; (vi) inability to meet emissions control standards; (vii) any cancellation or postponement of the SAE 2015 World Congress; and (viii) other risks and uncertainties discussed or referenced in the Company's filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K. In addition, any forward-looking statements represent the Company's estimates only as of the date of such statements and should not be relied upon as representing the Company's estimates as of any subsequent date. The Company specifically disclaims any obligation to update forward-looking statements. All forward-looking statements in this press release are qualified in their entirety by this cautionary statement.
Becky Herrick or Cathy Mattison LHA (IR Agency) +1 415 433 3777
